Peter Rothschild
About Peter H. Rothschild
Peter H. Rothschild (age 69) has served on The Wendy’s Company Board since 2010 (also a director of Wendy’s International from 2006–2008). He is a career investment banker and currently a Partner and head of the General Industries and Special Situations group at East Wind Advisors and its affiliated broker-dealer, East Wind Securities. He is an independent director and chairs the Compensation and Human Capital Committee; he also serves on the Audit, Nominating & Corporate Governance, and Executive Committees .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| East Wind Advisors, LLC / East Wind Securities, LLC | Partner; Head of General Industries and Special Situations | 2018–present | Strategic advisory leadership |
| Daroth Capital LLC / Daroth Capital Advisors LLC | Managing Member (Daroth Capital LLC); President & CEO (Daroth Capital Advisors LLC) | 2001–present (Managing Member); 2002–2018 (President & CEO) | Daroth Capital Advisors merged into East Wind Advisors in 2018 |
| Dresdner Kleinwort Wasserstein / Wasserstein Perella | Managing Director; Co-Head of Leveraged Finance and Industrial Finance | 1996–2001 | Leveraged finance leadership |
| Bear, Stearns & Co. Inc. | Senior Managing Director; Head, Natural Resources Group; Founder of Leveraged Finance & Financial Buyer Coverage groups | 1990–1996 | Built coverage platforms |
| Drexel Burnham Lambert | Managing Director | 1984–1990 | Investment banking leadership |
| The Wendy’s Company | Director | 2010–present | Independent director |
| Wendy’s International, Inc. | Director | 2006–2008 | Predecessor board service |
| Deerfield Capital Corp. (predecessor to CIFC Corp.) | Director; Interim Chairman | Director 2004–2011; Interim Chairman 2007–2011 | Board leadership during transition |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| The Mount Sinai Medical Center Samuel Bronfman Department of Medicine (NY) | Advisory Board Member | Current | Civic/healthcare advisory role |
| Middle Market Alliance of Long Island | Board Member | Current | Industry association governance |
| Tufts University Derby Entrepreneurial Center | Advisory Board Member | Current | Academic advisory role |
Board Governance
- Independence: Board affirmed Rothschild is independent under Nasdaq rules and the company’s Independence Standards .
- Committees and roles (2024): Compensation & Human Capital (Chair; also member of the Performance Compensation Subcommittee), Audit (Member), Nominating & Corporate Governance (Member), Executive (Member) .
- Attendance: The Board met nine times in 2024; each director attended at least 75% of total Board and relevant committee meetings. Overall Board/committee attendance was ~98% in 2024; all directors attended the 2024 annual meeting virtually .
- Pay-for-performance oversight: As C&HC Chair, Rothschild signed the Committee’s report and oversaw an executive program that received ~97% support in the 2024 say‑on‑pay vote .
Fixed Compensation (Director)
| Component (2024) | Amount |
|---|---|
| Fees earned or paid in cash | $128,874 |
| Stock awards (annual restricted stock grant) | $162,500 |
| All other compensation | — |
| Total | $291,374 |
Key program features affecting his cash fees and equity:
- Standard annual Board retainer $80,000; C&HC Chair retainer +$12,500; Audit Committee member retainer $14,000; Nominating & Corporate Governance member retainer $8,000; Executive Committee members receive $2,000 per meeting (no per‑meeting fees for Audit, C&HC, NCG, CSR, or Technology) .
- Non‑management director annual restricted stock award $162,500 (vests on earlier of first anniversary or next annual meeting; additional Chair equity retainer applies to Board Chair, not applicable to Rothschild) .
Performance Compensation (Director)
| Element | Design | Metric(s) | Vesting/Notes |
|---|---|---|---|
| Annual director equity | Restricted stock (time‑based) | None (no performance metrics) | Vests on earlier of first anniversary of grant or next annual meeting; directors may elect to defer into RSUs under the 2009 Directors’ Deferred Compensation Plan |
Directors are not subject to performance metrics; equity is time‑based and intended to align with shareholder interests .
Other Directorships & Interlocks
| Category | Detail |
|---|---|
| Current public company boards | None (as disclosed) |
| Prior public company boards | Deerfield Capital Corp., Director (2004–2011); Interim Chairman (2007–2011) |
| Committee interlocks | None disclosed for Rothschild on C&HC (committee interlock disclosures highlighted other members, not him) |
Expertise & Qualifications
- Investment banking since 1981 with extensive experience in finance, leveraged finance, corporate restructurings, M&A, strategic planning, human capital, franchising, and QSR industry dynamics; previously led major financing groups across multiple firms .
- Not designated as an “audit committee financial expert” (those designations apply to Arlin and Winkleblack), but serves on the Audit Committee and satisfies independence/financial literacy requirements with the committee as a whole meeting Nasdaq and SEC standards .
Equity Ownership
| Metric | Value | Notes |
|---|---|---|
| Beneficial ownership (common shares) | 164,170 | As of March 24, 2025; less than 1% of class |
| Restricted stock outstanding at 2024 FYE | 9,108 shares | Unvested restricted stock as of fiscal year‑end 2024 |
| Options outstanding at 2024 FYE | None | No directors had outstanding stock options at year‑end |
| Pledged shares | None | As of proxy date, none of the company’s executive officers or directors had pledged shares |
| Ownership guidelines | 5× annual cash Board retainer; hold 100% of net shares until met | Applies to all non‑management directors |
Governance Assessment
- Strengths
- Independent director with deep transactional and capital markets expertise; chairs the C&HC, which employs an independent consultant (FW Cook) and follows strong governance (clawbacks, double‑trigger CIC vesting, significant stock ownership guidelines) .
- Robust engagement outcomes (97% say‑on‑pay support in 2024) and clear disclosure of incentive design and outcomes; Board attendance and structure indicate effective oversight .
- No related‑party transactions involving Rothschild disclosed; Board reaffirmed his independence .
- Potential watch items
- General related‑party transactions disclosed at the company (e.g., purchases of advertising from AMC subsidiary; franchise royalties with Yellow Cab entities involving Peltz family interests) were reviewed/approved under the RPT policy; not linked to Rothschild but relevant to overall Board oversight of conflicts .
Committee Assignments Summary (2024)
| Committee | Role |
|---|---|
| Compensation & Human Capital | Chair; member of Performance Compensation Subcommittee |
| Audit | Member |
| Nominating & Corporate Governance | Member |
| Executive | Member |